Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 25 results in range #1 to #25.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265): Title
  2. Disclosure statement (from DOI: 10.1080/22221751.2020.1735265): Title
  3. Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265): Title
  4. Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265): Title
  5. Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265): Title
  6. Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265): Title
  7. Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265): Title
  8. Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265): Title
  9. Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265): Title
  10. Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265): Title
  11. Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265): Title
  12. Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265): Title
  13. Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265): Title
  14. Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265): Title
  15. Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265): Title
  16. Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265): Title
  17. Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265): Title
  18. Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265): Title, Statement: P146, Statement: P94, Other (Statements), Sitelink, Statement: P78, Statement: P125
  19. Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265): Title
  20. Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265): Title
  21. Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265): Title
  22. Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265): Title
  23. Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265): Title
  24. Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265): Title
  25. Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265): Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:EntityUsage/Q8402"